Education and Training
- Fellowship, Endocrinology, Brigham and Women's Hospital, 2017 - 2018
- Residency, Internal Medicine, Emory University School of Medicine, 2013 - 2016
- M.B.B.S., Imperial College London (United Kingdom), 2012
Alexopoulos, Anastasia-Stefania, Andreas Andersen, Anders Meller Donatsky, Amoolya Gowda, and John B. Buse. “Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100.” Diabetes Obes Metab 23, no. 8 (August 2021): 1983–88. https://doi.org/10.1111/dom.14397.
Alexopoulos, Anastasia-Stefania, Matthew J. Crowley, Ying Wang, Cynthia A. Moylan, Cynthia D. Guy, Ricardo Henao, Dawn L. Piercy, et al. “Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.” Hepatology, March 16, 2021. https://doi.org/10.1002/hep.31806.
Kobe, Elizabeth A., Clarissa J. Diamantidis, Hayden B. Bosworth, Clemontina A. Davenport, Megan Oakes, Anastasia-Stefania Alexopoulos, Jane Pendergast, Uptal D. Patel, and Matthew J. Crowley. “Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease.” Med Care 58, no. 11 (November 2020): 968–73. https://doi.org/10.1097/MLR.0000000000001387.
Yang, Jeff Y., Andrew M. Moon, Hannah Kim, Virginia Pate, A Sidney Barritt, Matthew J. Crowley, John B. Buse, Til Stürmer, and Anastasia-Stefania Alexopoulos. “Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes.” J Diabetes Complications 34, no. 11 (November 2020): 107706. https://doi.org/10.1016/j.jdiacomp.2020.107706.
Sagalla, Nicole, William S. Yancy, David Edelman, Amy S. Jeffreys, Cynthia J. Coffman, Corrine I. Voils, Anastasia-Stefania Alexopoulos, Matthew L. Maciejewski, Moahad Dar, and Matthew J. Crowley. “Factors associated with non-adherence to insulin and non-insulin medications in patients with poorly controlled diabetes.” Chronic Illn, October 25, 2020, 1742395320968627. https://doi.org/10.1177/1742395320968627.
Yang, Jeff Y., Anastasia Alexopoulos, Andrew M. Moon, Hannah Kim, Virginia Pate, A Sidney Barritt, Til Sturmer, and John B. Buse. “Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes.” In Pharmacoepidemiology and Drug Safety, 29:606–606, 2020.
Crowley, Matthew J., Darren K. McGuire, Anastasia-Stefania Alexopoulos, Thomas Jon Jensen, Søren Rasmussen, Hans A. Saevereid, Subodh Verma, and John B. Buse. “Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.” Diabetes Care 43, no. 9 (September 2020): e108–10. https://doi.org/10.2337/dc20-0437.
Lunyera, Joseph, Dinushika Mohottige, Anastasia-Stefania Alexopoulos, Hilary Campbell, C Blake Cameron, Nicole Sagalla, Timothy J. Amrhein, et al. “Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.” Ann Intern Med 173, no. 2 (July 21, 2020): 110–19. https://doi.org/10.7326/M20-0299.
Li, Dandan, Jocelyn Anne Silvester, Matthew J. Crowley, Jeff Y. Yang, Anastasia-Stefania Alexopoulos, Yang Xu, Siyan Zhan, and Tiansheng Wang. “Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.” Ther Adv Chronic Dis 11 (2020): 2040622320904301. https://doi.org/10.1177/2040622320904301.
Wolf, Rachel A., J Sonya Haw, Sudeshna Paul, Melissa Spezia Faulkner, EunSeok Cha, M. K. Findley, Farah Khan, et al. “Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital.” Diabetes Res Clin Pract 157 (November 2019): 107869. https://doi.org/10.1016/j.diabres.2019.107869.